164P Preliminary results from a phase I/II study of BDC-1001, a novel HER2 targeting TLR7/8 immune-stimulating antibody conjugate (ISAC), in patients (pts) with advanced HER2-expressing solid tumors

Annals of Oncology ◽

10.1016/j.annonc.2021.10.183 ◽

2021 ◽

Vol 32 ◽

pp. S1453-S1454

Author(s):

M.R. Sharma ◽

R.D. Carvajal ◽

G.J. Hanna ◽

Y.K. Kang ◽

J. Lee ◽

...

Keyword(s):

Phase I ◽

Solid Tumors ◽

Preliminary Results ◽

Antibody Conjugate

Download Full-text

A phase I dose escalation and pharmacokinetic (PK) study of intravenous aflibercept (VEGF trap) plus docetaxel (D) in patients (pts) with advanced solid tumors: Preliminary results

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.3599 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 3599-3599 ◽

Author(s):

N. Isambert ◽

G. Freyer ◽

S. Zanetta ◽

C. Falandry ◽

K. Soussan Lazard ◽

...

Keyword(s):

Phase I ◽

Solid Tumors ◽

Dose Escalation ◽

Advanced Solid Tumors ◽

Preliminary Results ◽

Download Full-text

282 POSTER Preliminary results of a Phase I accelerated dose-escalation, pharmacokinetic and pharmacodynamic study of PF-03814735, an oral Aurora kinase A and B inhibitor, in patients with advanced solid tumors

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(08)72216-x ◽

2008 ◽

Vol 6 (12) ◽

pp. 91 ◽

Author(s):

P. Schöffski ◽

H. Dumez ◽

S.F. Jones ◽

C. Fowst ◽

P. Gerletti ◽

...

Keyword(s):

Phase I ◽

Solid Tumors ◽

Dose Escalation ◽

Aurora Kinase ◽

Advanced Solid Tumors ◽

Aurora Kinase A ◽

Preliminary Results ◽

Pharmacodynamic Study ◽

Download Full-text

A phase I dose escalation and pharmacokinetic (PK) study of intravenous (iv) aflibercept (VEGF Trap) plus weekly gemcitabine (Gem) in patients (pts) with advanced solid tumors: preliminary results

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.3558 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 3558-3558 ◽

Author(s):

A. Patnaik ◽

M. Pipas ◽

L. S. Rosen ◽

L. Wood ◽

K. Phipps ◽

...

Keyword(s):

Phase I ◽

Solid Tumors ◽

Dose Escalation ◽

Advanced Solid Tumors ◽

Preliminary Results ◽

Download Full-text

620P MGC018, an anti-B7-H3 antibody-drug conjugate (ADC), in patients with advanced solid tumors: Preliminary results of phase I cohort expansion

Annals of Oncology ◽

10.1016/j.annonc.2021.08.1133 ◽

2021 ◽

Vol 32 ◽

pp. S657-S659

Author(s):

E. Shenderov ◽

G.H.G. Mallesara ◽

P.J. Wysocki ◽

W. Xu ◽

R. Ramlau ◽

...

Keyword(s):

Phase I ◽

Solid Tumors ◽

Advanced Solid Tumors ◽

Antibody Drug Conjugate ◽

Preliminary Results ◽

Drug Conjugate ◽

Download Full-text

Phase I and pharmacoklnetic (PK) study of irinotecan (CPT-11) and cisplatin in patients with solid tumors: Preliminary results

European Journal of Cancer ◽

10.1016/s0959-8049(97)86044-3 ◽

1997 ◽

Vol 33 ◽

pp. S251 ◽

Author(s):

M.J.A. de Jonge ◽

A. Spareboom ◽

A.S.Th. Planting ◽

M.E.L van der Burg ◽

P. de Bruijn ◽

...

Keyword(s):

Phase I ◽

Solid Tumors ◽

Preliminary Results

Download Full-text

Abstract C027: A Phase I, dose finding study of BI 754111, an anti-LAG-3 antibody, in combination with BI 754091, an anti-PD-1 antibody, in patients with advanced solid tumors: preliminary results from the microsatellite stable (MSS) metastatic colorectal cancer (mCRC) cohort

10.1158/1535-7163.targ-19-c027 ◽

2019 ◽

Author(s):

Johanna Bendell ◽

Susanna V Ulahannan ◽

Quincy Chu ◽

Manish Patel ◽

Ben George ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase I ◽

Metastatic Colorectal Cancer ◽

Solid Tumors ◽

Dose Finding ◽

Advanced Solid Tumors ◽

Preliminary Results ◽

Finding Study ◽

Dose Finding Study

Download Full-text

Phase I trial of a nucleoside analog CP-4055 given daily for 5 days every 3 weeks in patients (pts) with advanced solid tumors - preliminary results

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.2049 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 2049-2049 ◽

Author(s):

S. Aamdal ◽

S. Dueland ◽

M. J. Lind ◽

H. Thomas ◽

C. R. Franks ◽

...

Keyword(s):

Phase I ◽

Solid Tumors ◽

Phase I Trial ◽

Nucleoside Analog ◽

Advanced Solid Tumors ◽

Preliminary Results

Download Full-text

Preliminary results in colorectal cancer (CRC) patients enrolled in the GATTO study, a phase I study of Tomuzotuximab in combination with Gatipotuzumab in patients with EGFR positive solid tumors

Annals of Oncology ◽

10.1093/annonc/mdz157.009 ◽

2019 ◽

Vol 30 ◽

pp. iv125

Author(s):

E. Garralda ◽

W. Fiedler ◽

I. Matos ◽

C. Rolling ◽

M. Kebenko ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase I ◽

Solid Tumors ◽

Phase I Study ◽

Preliminary Results

Download Full-text

Biweekly docetaxel (DOC), gemcitabine (GEM), oxaliplatin (LOHP) in heavily pretreated patients with solid tumors — Preliminary results of a phase I study

European Journal of Cancer ◽

10.1016/s0959-8049(99)81576-7 ◽

1999 ◽

Vol 35 ◽

pp. S288 ◽

Author(s):

T. Büchele ◽

A. Grothey ◽

W. Voigt ◽

T. Kegel ◽

C. Rie ◽

...

Keyword(s):

Phase I ◽

Solid Tumors ◽

Phase I Study ◽

Preliminary Results ◽

Heavily Pretreated ◽

Pretreated Patients

Download Full-text

Abstract C173: A first-in-human Phase I study of DS-3078a, an oral TORC1/2 inhibitor, in patients with advanced solid tumors: Preliminary results.

10.1158/1535-7163.targ-13-c173 ◽

2013 ◽

Author(s):

Marta Capelan ◽

Prasana Kumar ◽

Anthony W. Tolcher ◽

Andrea Zivi ◽

Madhuri Desai ◽

...

Keyword(s):

Phase I ◽

Solid Tumors ◽

Phase I Study ◽

Advanced Solid Tumors ◽

Preliminary Results

Download Full-text